Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care
αDBS®, an Adaptive Deep Brain Stimulation system, is now certified for commercial use across the European Economic Area (EEA) and fully integrated with Newronika's WebBioBank™ neural data platform. MILAN, July 14, 2026 /PRNewswire/ -- Newronika S.p.A., the Milan-based medtech company...
αDBS®, an Adaptive Deep Brain Stimulation system, is now certified for commercial use across the European Economic Area (EEA) and fully integrated with Newronika's WebBioBank™ neural data platform. MILAN, July 14, 2026 /PRNewswire/ -- Newronika S.p.A., the Milan-based medtech company...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.